Long-Term Efficacy and Tolerability of Abdominal Once-Yearly Histrelin Acetate Subcutaneous Implants in Patients with Advanced Prostate Cancer

Table 1

Summary of baseline demographics.

Demographics	Mean
Age	74.9
Testosterone (ng/dL)	106.6
PSA (g/L)	12.1
Demographics	Percent
Caucasian	90.9
African American	8.1
Hispanic	1.0
Testosterone ≤ 30 ng/dL	48.5
PSA ≥ 5 µg/L	55.7
Previous LHRH agonist	44.9